ROTE WILLIAM E. 4
4 · Travere Therapeutics, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
ROTE WILLIAM E.
Chief Research Officer
Transactions
- Sale
Common Stock
2024-01-23$8.96/sh−2,062$18,476→ 60,484 total
Footnotes (2)
- [F1]This sale was made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Includes 1,373 shares of the Issuer's common stock acquired by the reporting person on November 30, 2023 pursuant to an employee stock purchase program.